Genome-wide CRISPR/Cas9 deletion screen defines mitochondrial gene essentiality and identifies routes for tumour cell viability in hypoxia
Luke W. Thomas(University of Cambridge), Margaret Ashcroft(Institute of Cancer Research)
Cited by 30
Related Papers
Pharmacological activation of a novel p53-dependent S-phase checkpoint involving CHK-1
|Cell Death and Disease|2011|32